Sunset Capital Assets, Inc. (SNST)

[Roland Rick Perry]

Our Favorite Hand Sanitizer Company, Aphex BioCleanse Systems Inc., is Now Publicly Traded!

We're updating our older report which delved into this amazing technology. We have visited the Port Richey manufacturing three times and it is a thing of beauty to see the giant tanks, as well as the 275 gallon totes which are being sold.

The updated report will be out tomorrow, a new report with notes from our facility visit is being prepared.

PERSONALLY, we believe the market for sanitizers can be 5 times larger than it currently is. We estimate this by 'observing' that only 10% of people in the U.S. are using sanitizer as we do (daily, everywhere we go) and as they should. As each month goes by, we believe that more and more people - worldwide - will start using sanitizer. The current count of infected is 18 million and the regular flu season is a short 3 months away. We would call that the peak sales season! Not just to avoid corona, but to avoid any flu!

Of course, some people (the reckless) will never use sanitizers or use masks - but the market is enormous today and destined to grow where it could support sales for APHX to exceed even the wildest imaginations.

And that's even BEFORE consumers accepting Aphex as the new standard which would mean UNSEATING alcohol from its perch - including Purell. Change takes time, but we are fully confident consumers will come to recognize APHEX as the new standard, after which Aphex could grow to the status of being a major pharma company.

The big difference compared to the biotech industry is that Aphex doesn't have to spend $100's of millions a year to support research. Past client Dicerna (DRNA) has a market cap today of $1.6 billion today (up from $68 million in 2017). The stock has gone from $3 to $24 since we found it and first reported on it. Trailing 12-month revenues at Dicerna were $30 million and they spent $60 million on research in the last three months alone! Yikes. It's a cash-burning machine. But some investors apparently understand the long-term potential as we did.

We have over 20 years of experience in Biotech and billions can be made when a new standard of care is introduced. Immunomedics (IMMU), our biggest winner ever has risen from $3 where we found it (with a lot of bumps along the way) and the market cap has risen from $280 million (2016) to $10.2 billion today. They lost $254 million last year, versus revenues of zero. We just raised our price target from $18 (in January) to $45 to $60 this July.

Visit the Internet | Biotech Stock Review for our updates.

Our Favorite Hand Sanitizer Company, Aphex BioCleanse Systems Inc., is Now Publicly Traded!

http://internetstockreview.com/our-favorite-hand-sanitizer-company-aphex-biocleanse-systems-inc-is-now-publicly-traded/

2020 Biotech Portfolio Soars 55%, We’re Amazed.

http://internetstockreview.com/2020-biotech-portfolio-soars-55-were-amazed-next-up-the-coming-gold-rush/

Client, see all reports for disclosure and disclaimer details.